$1.88
$29.00
52-Week Range
At a Glance
AI-generated6-K
NewcelX Ltd. announced a $1.35 million private placement financing priced at a 30% premium to market, involving the sale of common shares and warrants to support its Type 1 Diabetes program.$1M
Market Cap
—
Revenue
-$2M
Net Income
Employees11
Fundamentals
How The Business Makes Money
NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.
Industry Biotechnology
Activity
What Changed Recently
Company Profile
CIK0001783036
ISINCH1442297896
CUSIPH5835A109
Phone972 73 797 1600
AddressThe Circle 6, Zurich, 8058, CH
SEC EDGAR